Delayed
Hong Kong S.E.
10:39:32 2024-05-08 pm EDT
|
5-day change
|
1st Jan Change
|
5.38
HKD
|
-1.65%
|
|
-13.09%
|
+27.79%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,772
|
6,350
|
8,391
|
-
|
-
|
Enterprise Value (EV)
1 |
10,786
|
6,350
|
9,017
|
9,211
|
7,934
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
692
x
|
28.2
x
|
30
x
|
31
x
|
8.48
x
|
EV / Revenue
|
693
x
|
28.2
x
|
32.2
x
|
34.1
x
|
8.02
x
|
EV / EBITDA
|
-19.4
x
|
-22
x
|
-43.3
x
|
-29.7
x
|
-69.5
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
12
x
|
-
|
13.3
x
|
25.3
x
|
50.6
x
|
Nbr of stocks (in thousands)
|
1,659,445
|
1,659,445
|
1,659,445
|
-
|
-
|
Reference price
2 |
6.491
|
3.827
|
5.057
|
5.057
|
5.057
|
Announcement Date
|
3/17/23
|
3/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
15.57
|
225.4
|
279.8
|
270.3
|
989
|
EBITDA
1 |
-555.9
|
-288.4
|
-208.3
|
-310.6
|
-114.2
|
EBIT
1 |
-704.5
|
-391
|
-371.3
|
-470.8
|
-267.7
|
Operating Margin
|
-4,524.03%
|
-173.48%
|
-132.74%
|
-174.19%
|
-27.07%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/17/23
|
3/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
14.2
|
-
|
626
|
820
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
457
|
Leverage (Debt/EBITDA)
|
-0.0255
x
|
-
|
-3.003
x
|
-2.64
x
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-79.3%
|
-
|
-34%
|
-61.8%
|
-65.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
0.5400
|
-
|
0.3800
|
0.2000
|
0.1000
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/17/23
|
3/27/24
|
-
|
-
|
-
|
Last Close Price
5.057
CNY Average target price
4.613
CNY Spread / Average Target -8.77% Consensus |
1st Jan change
|
Capi.
|
---|
| +27.79% | 1.12B | | +2.93% | 106B | | +7.02% | 23.47B | | -14.60% | 21.9B | | -7.05% | 18.77B | | -38.55% | 17.85B | | -8.83% | 16.78B | | +5.51% | 14.41B | | +37.49% | 12.86B | | +329.39% | 8.78B |
Bio Therapeutic Drugs
|